Tepotinib Hydrochloride
Tepotinib Hydrochloride is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including TEPMETKO. Available dosage form: tablet.
Drug Details
- Generic Name
- Tepotinib Hydrochloride
- Brand Names
- TEPMETKO
- Application Number
- NDA214096
- Sponsor
- EMD Serono, Inc.
- NDC Codes
- 1
- Dosage Forms
- TABLET
- Routes
- ORAL
- Active Ingredients
- TEPOTINIB HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE TEPMETKO is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition ( MET ) exon 14 skipping alterations. TEPMETKO is a kinase inhibitor indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition ( MET ) exon 14 skipping alterations. ( 1 )